[1]
« The urgency to treat optimally and to target: Avoiding long-term complications in type 2 diabetes with a focus on GLP-1 receptor agonists », Can Prim Care Today, vol. 1, nᵒ S07, p. 2–6, juill. 2023, doi: 10.58931/cpct.2023.1S0717.